Duodenum-Preserving Pancreatic Head Resection for Benign and Premalignant Tumors—a Systematic Review and Meta-analysis of Surgery-Associated Morbidity - Takeaways - MDSpire

Duodenum-Preserving Pancreatic Head Resection for Benign and Premalignant Tumors—a Systematic Review and Meta-analysis of Surgery-Associated Morbidity

  • By

  • Hans G. Beger

  • Benjamin Mayer

  • Bertram Poch

  • September 5, 2023

  • 0 min

Share

  • 1

    Pancreatoduodenectomy is the standard treatment for pancreatic head cancer, but it poses significant risks of complications and long-term metabolic morbidity.

  • 2

    Duodenum-preserving pancreatic head resection (DPPHR) offers lower rates of new-onset diabetes and pancreatic exocrine insufficiency compared to traditional methods.

  • 3

    The prevalence of benign pancreatic tumors is increasing due to advanced imaging techniques, with 15-20% of resections performed for benign or premalignant conditions.

  • 4

    This systematic review aims to evaluate early postoperative morbidity associated with DPPHR compared to pancreatoduodenectomy for benign tumors.

  • 5

    The methodological quality of the included studies was assessed using established criteria to ensure reliable evidence for the analysis.

Original Source(s)

Duodenum-Preserving Pancreatic Head Resection for Benign and Premalignant Tumors—a Systematic Review and Meta-analysis of Surgery-Associated Morbidity

  • by Hans G. Beger, Benjamin Mayer, Bertram Poch

  • September 5, 2023

Related Content

Enduring Surgical Approach: The Systemic-to-Pulmonary Artery Shunt in Congenital Heart Defect Management

Lactate–Albumin Ratio Tied to TBI Mortality

Admission biomarker showed prognostic value alongside clinical scoring systems in pediatric intensive care

Visceral fat area and blood lipids in colorectal cancer: predictors of surgical risk and prognosis